Therapy Areas: Diabetes
Astellas Pharma signs agreement with Roche Diabetes Care Japan
29 March 2023 - Astellas Pharma Inc. (TSE:4503), a Japan-based pharmaceutical company, announced on Tuesday that it has signed an agreement with Roche Diabetes Care Japan Co., Ltd., a global company i...
Ionis Pharmaceuticals announces positive topline results from eplontersen Phase three NEURO-TTRansform study
27 March 2023 - Ionis Pharmaceuticals, Inc. (Nasdaq:IONS), a United States-based biotechnology company, announced on Monday positive topline results from the 66-week evaluation of the Phase three NEUR...
Creative Medical Technology files FDA Orphan Drug Designation application for ImmCelz(CELZ-100) platform to treat Brittle Type 1 Diabetes
24 March 2023 - Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a US-based biotechnology company, announced on Thursday that it has filed an application with the US Food and Drug Administra...
Dexcom's real-time CGM System to be available in Manitoba for diabetes management
21 March 2023 - Dexcom Inc (NASDAQ: DXCM), a provider of real-time continuous glucose monitoring (rtCGM) for diabetes patients, declared on Tuesday that it Dexcom G6 CGM System will be available to el...
Vertex Receives FDA Clearance of Investigational New Drug Application for VX-264, a Novel Encapsulated Cell Therapy for the Treatment of Type 1 Diabetes
16 March 2023 - - The US Food and Drug Administration has cleared the Investigational New Drug Application for VX-264, a stem cell-derived, fully differentiated pancreatic islet cell therapy encapsula...
Sanofi to acquire Provention Bio, adding diabetes drug TZIELD
13 March 2023 - French healthcare company Sanofi S.A. (Euronext Paris: SAN) (Nasdaq: SNY) and Provention Bio Inc announced on Monday an agreement for Sanofi to acquire US-based Provention Bio (Nasdaq:...